002550.SZ
002550.SZ
CNE100001070
QIANHONG BIO-PHARMA
Loading chart...

Company Profile

Changzhou Qianhong Biopharma CO.,LTD manufactures and distributes polysaccharide and protease drugs in China. The company offers heparin sodium, heparin calcium, enoxaparin sodium, dalteparin sodium, nadroparin calcium, pancreatin, heparinoid API, kallidinogenase, and asparaginase, as well as offers berry source and target diet box. It also provides low molecular weight heparin, compound digestive enzyme preparations, and health products. In addition, the company exports its products. The company was founded in 1971 and is headquartered in Changzhou, China.

Related stocks

300026.SZ
300026.SZ • China
CHASE SUN PHARM.
3.32 CNY
1.49B USD 1Y -10.8%
688276.SS
688276.SS • China
CHANGCHUN BCHT BIOTECHNOLOGY CO
17.79 CNY
1.1B USD 1Y -19.6%
000597.SZ
000597.SZ • China
NEP.
4.91 CNY
1.05B USD 1Y -10.2%
600252.SS
600252.SS • China
GUANGXI WUZHOU ZHONGHENG GROUP
2.25 CNY
1.07B USD 1Y -17.6%
000756.SZ
000756.SZ • China
XINHUA PHARM
14.81 CNY
1.54B USD 1Y -5.5%
002332.SZ
002332.SZ • China
XJZY
8.76 CNY
1.3B USD 1Y -11.2%
002349.SZ
002349.SZ • China
JINGHUA PHARM
9.24 CNY
1.15B USD 1Y +28.3%
600488.SS
600488.SS • China
TIANJIN TIANYAO PHARMACEUTICAL
6.47 CNY
1.06B USD 1Y +59%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
42.1% p.a.
Max Drawdown (5Y)
-52.9%
Sharpe Ratio (5Y)
0.13
Beta Factor
0.02
Size Class
Mid Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (42.1% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -60.6% in the extended horizon.
ende